Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
bio
biology
editas medicine
jennifer doudna
1963 births
abbvie
allergan
alzheimer's disease
american biochemists
american women scientists
berkeley college of chemistry faculty
biological engineering
biotech
biotechnology
boston
boston blog main
boston top stories
broad institute
clinical trials
crystallographers
cynthia collins
deals
drama
emerging technologies
engineering disciplines
enzymes
gene editing
genetic engineering
genetics
harvard university alumni
howard hughes medical investigators
leber congenital amaurosis type 10
life sciences
living people
members of the national academy of medicine
members of the united states national academy of sciences
michelle robertson
molecular biology
national blog main
What
editing
gene
3
×
rights
3
×
berkeley’s
cas
crispr
doudna
institute
jennifer
patent
read
abbvie
actually
alliance
argument
arguments
begin
berkeley
biotech
broad
california
came
case
charpentier
colleague
contender
court
date
december
decision
delighted
disputed
doudna’s
editas
emmanuelle
exits
experimental
favor
feng
forward
Language
unset
Current search:
rights
×
gene
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@techcrunch.com
7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
